Evommune, Inc. (NYSE:EVMN) People

Evommune, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajeev M Shah
Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past)
Director · Since at least Nov 5, 2025
Arthur Kirsch
Other companies: Atea Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Liquidia Corporation (Board Member · Since at least Mar 24, 2021); Kadmon Holdings Inc (Director · May 15, 2019 – Nov 9, 2021 · Past); Aralez Pharmaceuticals Inc (Director · May 12, 2016 – Dec 8, 2017 · Past)
Audit · Since at least Nov 5, 2025
Derek DiRocco
Other companies: Mineralys Therapeutics, Inc. (Board Member · Since at least Nov 5, 2026); Acrivon Therapeutics, Inc. (Director · Since at least May 18, 2026)
Board Member · Since at least Nov 4, 2026
Gregory S. Moss
Other companies: Anteris Technologies Global Corp. (Director · Since at least Jun 7, 2025); Kadmon Holdings Inc (EVP, Gen. Coun. / CCO. · Aug 30, 2019 – Nov 9, 2021 · Past)
Chief Business and Legal Officer · Since at least Nov 5, 2025
Benjamin F McGraw III
Other companies: Aerie Pharmaceuticals Inc. (Director · Jun 17, 2021 – Nov 21, 2022 · Past)
Director · Since at least Nov 5, 2025
David E. Cohen
Other companies: Timber Pharmaceuticals Inc (Director · Apr 15, 2022 – Apr 15, 2023 · Past)
Director · Since at least Nov 5, 2025
Eugene Bauer
Other companies: Kadmon Holdings Inc (Director · May 15, 2019 – Nov 9, 2021 · Past)
Executive Director, Chief Medical Officer · Since at least Nov 5, 2025
Andrea KimVice President, Nonclinical Development · Since at least Nov 4, 2026
Benjamin F. McGrawChair of Board · Since at least Nov 4, 2026
Felice Verduyn-van WeegenNominating and Corporate Governance · Since at least Nov 4, 2026
Janice DrewChief of Development Operations · Since at least Jun 24, 2026
Jeegar PatelChief Scientific Officer · Since at least Nov 5, 2025
J. Mark JacksonSenior Vice President, Clinical Development · Since at least Nov 5, 2026
Kyle CarverChief Financial Officer · Since at least Nov 5, 2025
Lou SehlSenior Vice President, Technical Operations · Since at least Nov 4, 2026
Luis PeñaExecutive Director, President & Chief Executive Officer · Since at least Nov 5, 2025
Megan HumphreysVice President, Corporate Communications · Since at least Oct 1, 2026
Rob HopfnerAudit · Since at least Nov 4, 2026